Massimilliano La Colla

Head of Biology at WaveGuide, Dr. La Colla brings nearly two decades of research experience in biotech R&D and diagnostics. An accomplished cell biologist who guides and support the efforts of several programs, responsible for method development across all markets and fields-of-use from biologics to food safety, oil & gas, and through the initial research in medical diagnostics with tuberculosis and ovarian cancer screening.

Dr. La Colla manages the company’s TD-NMR (time domain nuclear magnetic resonance) experiments in the DEA certified laboratory and is a subject matter expert on the FDA 510(k) pathways for tuberculosis and ovarian cancer screening with the use of MNPs (magnetic nanoparticles).

Prior to joining WaveGuide in 2016, Dr. La Colla held various positions with Idenix Pharmaceuticals (a division of Merck & Co.) as an investigator for new drug targets for conditions including cancer, anti-virals for new inhibitors of Dengue, RSV (respiratory syncytial virus), and HPV (hepatitis C virus).

Dr. La Colla received his Ph.D. in Cellular and Molecular Biology at the Universita Cattolica del Sacro Cuore (UCSC) in Milan Italy.